Cancer Prevention News

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

PHILADELPHIA — Patients with a false-positive Shield test result did not appear to be at increased risk for non-colorectal cancer malignancies at 1 year compared with those with a true-negative result, according to a presenter here.

ORLANDO — In patients with monoclonal gammopathy of undetermined significance and elevated BMI, a plant-based, high-fiber diet improved metabolic and microbiome profiles and immune subsets, according to a study.

Combining high consumption of tea with physical activity could substantially decrease the risk for death, results from a cohort analysis suggested.

An invitation to screen for Helicobacter pylori along with fecal immunochemical testing did not significantly reduce gastric cancer incidence or mortality over approximately 5 years vs. FIT alone, according to a study conducted in Taiwan.

Disease-free survival at 3 years was significantly higher among patients with screen-detected colorectal cancer vs. those with clinically detected CRC, according to a study conducted in the Netherlands.

The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer, according to a company press release.

Delays in cancer registration may have underestimated 10-year colorectal cancer risk reductions by up to 75% in the NordICC trial, with researchers warning that study estimates on screening colonoscopy should be “interpreted with caution.”

Adults diagnosed with endogenous Cushing’s syndrome have a higher risk for developing cancer compared with controls without the condition, according to data published in the European Journal of Endocrinology.